Northern Trust Company of Connecticut’s Haemonetics HAE Stock Holding History

Northern Trust Company of Connecticut’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$3.47M	Hold	82,364	–	–	0.02%	840
2013 Q3	$3.29M	Hold	82,364	–	–	0.02%	854
2013 Q2	$3.41M	Buy	+82,364	New	+$3.33M	0.02%	803

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Northern Trust Company of Connecticut's HAE Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Haemonetics (HAE) position steady in Q4 2013 at 82,364 shares worth $3.47M. The position accounts for 0.02% of the portfolio, ranked #840.

Northern Trust Company of Connecticut first reported a position in HAE in Q2 2013 and has held it in 3 quarters since. 196 funds tracked by Wall St. Rank hold HAE as of Q4 2013.

Northern Trust Company of Connecticut held 82,364 shares of Haemonetics worth $3.47M as of Q4 2013.
Northern Trust Company of Connecticut left its Haemonetics share count unchanged in Q4 2013.
Haemonetics made up 0.02% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #840 holding.
Northern Trust Company of Connecticut first reported a position in Haemonetics in Q2 2013 and has held it in 3 quarters since.
196 funds tracked by Wall St. Rank held Haemonetics as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.